Affidea announces MPG Acquisition
Affidea, the leading European provider of diagnostic imaging, outpatient and cancer care services announces that it has successfully completed the acquisition of UAB Medicinos Paslaugų Grupė (MPG) in Lithuania. With this step, Affidea’s network reaches 256 centers at European level, working with over 9000 professionals and seeing more than 7 million patients every year.
This latest investment doubles Affidea’s presence in Lithuania – with the local network growing from 11 centers to 23 across the country.
Medicinos Paslaugų Grupė is an important private healthcare service provider in Lithuania, with a wide network of 12 outpatient and diagnostic imaging clinics in eight cities across the country. The newly added MPG centers in Lithuania will provide patients with a wide range of medical services from vaccination and occupational services to diagnostic imaging (MRI, CT and X-ray), laboratory, specialist consultations and health checks, seeing more than 250.000 patients every year at country level.
In a further sign of Affidea’s commitment to strengthen its leadership position across Europe and expand its outpatient services offer , MPG acquisition in Lithuania follows the recent expansion in Italy, with the acquisition of Medicenter clinics in Rome, Monterotondo and Terni and in Ireland with the opening of the third ExpressCare clinic for minor injuries and minor illnesses, in north Dublin.
Commenting on the latest expansion announcements, Giuseppe Recchi, Affidea Group CEO, said: “It is an exciting period for our growth story. We have now reached 256 centres across Europe and have a strong appetite for continued growth. The recently announced acquisitions in Lithuania and Italy, alongside with the opening of the new ExpressCare in Ireland, marks important milestones in our development and supports our long-standing commitment to further expand into high quality outpatient care services locally and at European level. We are well placed to accelerate on our growth journey, looking for the right opportunities across Europe to further bolster our portfolio of healthcare assets”.